Skip to main content
Netramark Holdings Inc. logo

Netramark Holdings Inc. — Investor Relations & Filings

Ticker · AIAI ISIN · CA64119M1059 LEI · 391200VOK8WHERIX0Q06 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 336 across all filing types
Latest filing 2023-01-20 AGM Information
Country CA Canada
Listing CSE AIAI

About Netramark Holdings Inc.

https://www.netramark.com/

Netramark Holdings Inc. develops and deploys advanced Artificial Intelligence (AI) and Machine Learning (ML) solutions specifically for the pharmaceutical industry, focusing on optimizing clinical trial design and outcomes. Its core product, NetraAI, is an AI platform powered by the proprietary Attractor AI algorithm. NetraAI analyzes complex, multimodal clinical trial datasets to uncover hidden patient correlations and causal factors, providing high clarity and explainability. The platform delivers AI-powered insights to trial sponsors, clinical research organizations, and biotechnology companies. These insights are used to inform protocol design, identify optimal patient subpopulations, determine effective dosage, enhance enrichment strategies, and improve inclusion/exclusion criteria, thereby increasing effect sizes and minimizing clinical trial risks.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
AGM Information Classification · 90% confidence The document is a notice regarding the upcoming Annual General and Special Meeting of Nurosene Health Inc., including details such as meeting date, record date, and voting information. It does not contain the actual meeting materials or reports but serves as an announcement of the meeting and related dates. The document length is short (1115 characters), and it primarily provides logistical information about the meeting rather than substantive content like financials or management discussion. Therefore, it fits best under AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices related to it.
2023-01-20 English
News release - English.pdf
Regulatory Filings
2023-01-18 English
News release - English.pdf
Regulatory Filings
2022-12-06 English
News release - English.pdf
Investor Presentation Classification · 85% confidence The document is a business update from Nurosene Health Inc. It provides a strategic overview of the company's focus on AI/ML solutions for the pharmaceutical industry, details about the NetraAI platform, market opportunity, challenges, and recent executive hires. It does not contain financial statements, quarterly or annual results, nor does it announce voting results, legal proceedings, or capital changes. The document is a narrative business update aimed at informing investors and stakeholders about the company's strategic direction and operational focus. It is not a formal financial report, regulatory filing, or presentation. Given the content and length (9474 characters), it fits best as a general business update or investor communication. The closest fitting category in the provided list is "Investor Presentation (IP)" since it focuses on business strategy and market position, although it is not a formal slide deck, it aligns better than other categories. Therefore, the classification is Investor Presentation (IP) with high confidence.
2022-12-01 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer details, distribution dates, types of securities distributed, purchaser information, and net proceeds by jurisdiction. It is a regulatory filing related to exempt distributions of securities in Canada, which is a specific compliance report rather than a financial report like an annual or quarterly report. The document is not an announcement or a brief summary but a formal regulatory report required by securities regulators. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-11-01 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the closing of a private placement financing by Nurosene Health Inc. It details the issuance of units, common shares, warrants, and broker warrants, along with the use of proceeds and share count after the financing. There are no financial statements or detailed financial performance data included. The document is focused on capital raising activity and related securities issuance. It is not an annual report, earnings release, or management discussion. The document length is 4432 characters, which is relatively short and typical for a financing announcement. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-10-31 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.